BMAL1 and cancer: Analysis of multiple human cancer (TCGA) samples revealed that an index of higher core circadian clock gene (BMAL1, PER1/2/3, CRY1/2, CLOCK) expression is related to downregulated MMR pathways, possibly indicating the occurrence of fewer mismatch events, though this was not directly assessed [56].